PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $300,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. 1 filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the registrant's LDA id (401103605), not by name.

Clients 1

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION $300,000 6 filings

Lobbyists named 1

GIL ROTH 7 filings · through 2026 not applicable

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $100,000 2 filings
2025 $200,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

HOUSE OF REPRESENTATIVES 5
Bureau of Industry and Security (BIS) 3
SENATE 3
Commerce, Dept of (DOC) 2
State, Dept of (DOS) 1
White House Office 1

Recent filings 7 total

Q2

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2026 · $50,000 expenses · posted Jul 14, 2026

View → Q1

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $50,000 expenses · posted Apr 22, 2026

View → Q4

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000 expenses · posted Jan 16, 2026

View → 3A

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

3rd Quarter (July 1 - Sep 30) 2025 · House · $50,000 expenses · posted Oct 1, 2025

View → Q3

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION Amended

3rd Quarter (July 1 - Sep 30) 2025 · House · $50,000 expenses · posted Oct 1, 2025

View → Q2

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2025 · House · $50,000 expenses · posted Jul 8, 2025

View → Q1

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $50,000 expenses · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.